Contact

Juravine Home About Services Country Table Legal Guides Resources Hub Contact A jurisdictional starting point Ibogaine Legal Status: Country-by-Country Table Rules around a potent psychoactive substance are not uniform. This guide separates controlled-substance rules, medical access, research, and practical uncertainty without treating any country as a simple yes-or-no answer. Updated for a changing global perspective Scope before decisions Understanding ibogaine in law and context Ibogaine is a naturally occurring psychoactive alkaloid found in the root bark of the Tabernanthe iboga plant, native to Central and West Africa, particularly Gabon and Cameroon. The iboga plant is often discussed as plant medicine, but a law may treat the molecule, root bark, seeds, extracts, medicines, and commercial services differently. Its hallucinogenic properties and pharmacological properties are central to legal scrutiny. Ibogaine can interact with multiple neurotransmitter systems, including serotonin, dopamine, and opioid receptors; an overview of the compound’s history and classification is available through the Wikipedia entry on ibogaine . For centuries, indigenous communities associated with Bwiti spiritual practices in Gabon have used iboga in ceremonial healing, spiritual journeys, and rites of passage. That traditional medicine context does not automatically establish legal permission for possession, export, medical use, or ibogaine treatment elsewhere. A closer account of Bwiti practice and iboga helps distinguish cultural use from contemporary regulation. Country labels are snapshots, not guarantees: national law, regional rules, licensing, imports, and professional standards can point in different directions. How to use the table “Restricted” can mean a controlled substance, a prescription drug pathway, research-only authorization, or a legal grey area. “More permissive” does not mean that patient safety, professional practice, or import rules are settled. For a broad

Contact

A careful place to begin